These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31026862)

  • 1. Kappa-opioid receptors, dynorphin, and cocaine addiction: a positron emission tomography study.
    Martinez D; Slifstein M; Matuskey D; Nabulsi N; Zheng MQ; Lin SF; Ropchan J; Urban N; Grassetti A; Chang D; Salling M; Foltin R; Carson RE; Huang Y
    Neuropsychopharmacology; 2019 Sep; 44(10):1720-1727. PubMed ID: 31026862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the agonist PET radioligand [¹¹C]GR103545 to image kappa opioid receptor in humans: kinetic model selection, test-retest reproducibility and receptor occupancy by the antagonist PF-04455242.
    Naganawa M; Jacobsen LK; Zheng MQ; Lin SF; Banerjee A; Byon W; Weinzimmer D; Tomasi G; Nabulsi N; Grimwood S; Badura LL; Carson RE; McCarthy TJ; Huang Y
    Neuroimage; 2014 Oct; 99():69-79. PubMed ID: 24844744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kappa opioid receptor binding in major depression: A pilot study.
    Miller JM; Zanderigo F; Purushothaman PD; DeLorenzo C; Rubin-Falcone H; Ogden RT; Keilp J; Oquendo MA; Nabulsi N; Huang YH; Parsey RV; Carson RE; Mann JJ
    Synapse; 2018 Sep; 72(9):e22042. PubMed ID: 29935119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate and Persistent Effects of Salvinorin A on the Kappa Opioid Receptor in Rodents, Monitored In Vivo with PET.
    Placzek MS; Van de Bittner GC; Wey HY; Lukas SE; Hooker JM
    Neuropsychopharmacology; 2015 Dec; 40(13):2865-72. PubMed ID: 26058662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral stress may increase the rewarding valence of cocaine-associated cues through a dynorphin/kappa-opioid receptor-mediated mechanism without affecting associative learning or memory retrieval mechanisms.
    Schindler AG; Li S; Chavkin C
    Neuropsychopharmacology; 2010 Aug; 35(9):1932-42. PubMed ID: 20445500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic Modeling and Test-Retest Reproducibility of
    Naganawa M; Li S; Nabulsi N; Lin SF; Labaree D; Ropchan J; Gao H; Mei M; Henry S; Matuskey D; Carson RE; Huang Y
    J Nucl Med; 2020 Nov; 61(11):1636-1642. PubMed ID: 32169917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.
    Zhou L; Stahl EL; Lovell KM; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
    Neuropharmacology; 2015 Dec; 99():131-41. PubMed ID: 26160155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction.
    Karkhanis A; Holleran KM; Jones SR
    Int Rev Neurobiol; 2017; 136():53-88. PubMed ID: 29056156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala.
    Nygard SK; Hourguettes NJ; Sobczak GG; Carlezon WA; Bruchas MR
    J Neurosci; 2016 Sep; 36(38):9937-48. PubMed ID: 27656031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging Kappa Opioid Receptors in the Living Brain with Positron Emission Tomography.
    Placzek MS
    Handb Exp Pharmacol; 2022; 271():547-577. PubMed ID: 34363128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging glutamate homeostasis in cocaine addiction with the metabotropic glutamate receptor 5 positron emission tomography radiotracer [(11)C]ABP688 and magnetic resonance spectroscopy.
    Martinez D; Slifstein M; Nabulsi N; Grassetti A; Urban NB; Perez A; Liu F; Lin SF; Ropchan J; Mao X; Kegeles LS; Shungu DC; Carson RE; Huang Y
    Biol Psychiatry; 2014 Jan; 75(2):165-71. PubMed ID: 24035345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Kappa opioid receptor blockade by LY2444296 HCl, a selective short-acting antagonist, during chronic extended access cocaine self-administration and re-exposure in rat.
    Valenza M; Windisch KA; Butelman ER; Reed B; Kreek MJ
    Psychopharmacology (Berl); 2020 Apr; 237(4):1147-1160. PubMed ID: 31915862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake.
    Schindler AG; Messinger DI; Smith JS; Shankar H; Gustin RM; Schattauer SS; Lemos JC; Chavkin NW; Hagan CE; Neumaier JF; Chavkin C
    J Neurosci; 2012 Dec; 32(49):17582-96. PubMed ID: 23223282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrepancies in Kappa Opioid Agonist Binding Revealed through PET Imaging.
    Placzek MS; Schroeder FA; Che T; Wey HY; Neelamegam R; Wang C; Roth BL; Hooker JM
    ACS Chem Neurosci; 2019 Jan; 10(1):384-395. PubMed ID: 30212182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role for kappa-opioid system in stress-induced cocaine use uncovered with PET.
    Blevins D; Martinez D
    Neuropsychopharmacology; 2020 Jan; 45(1):233-234. PubMed ID: 31501528
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptors.
    Grimwood S; Lu Y; Schmidt AW; Vanase-Frawley MA; Sawant-Basak A; Miller E; McLean S; Freeman J; Wong S; McLaughlin JP; Verhoest PR
    J Pharmacol Exp Ther; 2011 Nov; 339(2):555-66. PubMed ID: 21821697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of in vivo Bmax and Kd for 11C-GR103545, an agonist PET tracer for κ-opioid receptors: a study in nonhuman primates.
    Tomasi G; Nabulsi N; Zheng MQ; Weinzimmer D; Ropchan J; Blumberg L; Brown-Proctor C; Ding YS; Carson RE; Huang Y
    J Nucl Med; 2013 Apr; 54(4):600-8. PubMed ID: 23424192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system.
    Land BB; Bruchas MR; Lemos JC; Xu M; Melief EJ; Chavkin C
    J Neurosci; 2008 Jan; 28(2):407-14. PubMed ID: 18184783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locus coeruleus kappa-opioid receptors modulate reinstatement of cocaine place preference through a noradrenergic mechanism.
    Al-Hasani R; McCall JG; Foshage AM; Bruchas MR
    Neuropsychopharmacology; 2013 Nov; 38(12):2484-97. PubMed ID: 23787819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynorphin activation of kappa opioid receptor reduces neuronal excitability in the paraventricular nucleus of mouse thalamus.
    Chen Z; Tang Y; Tao H; Li C; Zhang X; Liu Y
    Neuropharmacology; 2015 Oct; 97():259-69. PubMed ID: 26056031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.